Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.

Cancer Med · 2023 · PMC10417130 · PMID 37212507

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Conversely, ELN17 adverse genetic risk was associated with higher CIR, although this association did not reach statistical significance: HR 2.85 (95% CI 0.95–8.57), p = 0.06.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.